FMP
Enzon Pharmaceuticals, Inc.
ENZN
PNK
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
0.11 USD
0.0009 (0.818%)
Valuation Date:
Mar 21, 2025 4:00 PM
Share Price on Valuation Date
$0.11
Stock Beta
0.262
Shares Outstanding
74214600